chr15-90999107-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018668.5(VPS33B):c.1775-53G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 1,573,576 control chromosomes in the GnomAD database, including 15,305 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 2221 hom., cov: 32)
Exomes 𝑓: 0.10 ( 13084 hom. )
Consequence
VPS33B
NM_018668.5 intron
NM_018668.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.647
Genes affected
VPS33B (HGNC:12712): (VPS33B late endosome and lysosome associated) Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene is a member of the Sec-1 domain family, and encodes the human ortholog of rat Vps33b which is homologous to the yeast class C Vps33 protein. The mammalian class C vacuolar protein sorting proteins are predominantly associated with late endosomes/lysosomes, and like their yeast counterparts, may mediate vesicle trafficking steps in the endosome/lysosome pathway. Mutations in this gene are associated with arthrogryposis-renal dysfunction-cholestasis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-90999107-C-T is Benign according to our data. Variant chr15-90999107-C-T is described in ClinVar as [Benign]. Clinvar id is 1288168.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.455 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS33B | NM_018668.5 | c.1775-53G>A | intron_variant | Intron 22 of 22 | ENST00000333371.8 | NP_061138.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS33B | ENST00000333371.8 | c.1775-53G>A | intron_variant | Intron 22 of 22 | 1 | NM_018668.5 | ENSP00000327650.4 | |||
ENSG00000284946 | ENST00000643536.1 | n.1774+570G>A | intron_variant | Intron 22 of 34 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes AF: 0.143 AC: 21782AN: 151990Hom.: 2213 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21782
AN:
151990
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.104 AC: 148459AN: 1421468Hom.: 13084 Cov.: 24 AF XY: 0.105 AC XY: 74482AN XY: 707820 show subpopulations
GnomAD4 exome
AF:
AC:
148459
AN:
1421468
Hom.:
Cov.:
24
AF XY:
AC XY:
74482
AN XY:
707820
Gnomad4 AFR exome
AF:
AC:
6451
AN:
32834
Gnomad4 AMR exome
AF:
AC:
13580
AN:
42756
Gnomad4 ASJ exome
AF:
AC:
1886
AN:
25706
Gnomad4 EAS exome
AF:
AC:
19653
AN:
39374
Gnomad4 SAS exome
AF:
AC:
15293
AN:
83968
Gnomad4 FIN exome
AF:
AC:
4002
AN:
52808
Gnomad4 NFE exome
AF:
AC:
79404
AN:
1079188
Gnomad4 Remaining exome
AF:
AC:
7268
AN:
59158
Heterozygous variant carriers
0
6896
13792
20688
27584
34480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
3394
6788
10182
13576
16970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.143 AC: 21806AN: 152108Hom.: 2221 Cov.: 32 AF XY: 0.148 AC XY: 10995AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
21806
AN:
152108
Hom.:
Cov.:
32
AF XY:
AC XY:
10995
AN XY:
74362
Gnomad4 AFR
AF:
AC:
0.190532
AN:
0.190532
Gnomad4 AMR
AF:
AC:
0.255304
AN:
0.255304
Gnomad4 ASJ
AF:
AC:
0.0797811
AN:
0.0797811
Gnomad4 EAS
AF:
AC:
0.470531
AN:
0.470531
Gnomad4 SAS
AF:
AC:
0.194479
AN:
0.194479
Gnomad4 FIN
AF:
AC:
0.0726552
AN:
0.0726552
Gnomad4 NFE
AF:
AC:
0.0763801
AN:
0.0763801
Gnomad4 OTH
AF:
AC:
0.148534
AN:
0.148534
Heterozygous variant carriers
0
892
1784
2676
3568
4460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1051
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at